Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-08

Clinical Trial Update: Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"

View source ↗

Summary

Clinical trial update for alogliptin tablets investigating monotherapy and combination therapy with alpha-glucosidase inhibitor in type 2 diabetes mellitus; stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alogliptin tablets (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institution | Status: COMPLETED | Results posted: 2018-11-08